Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Legal AI startup Legora raises $550 million to speed up US expansion
-
Bain Capital nears final close of record $10.5 billion Asia fund, sources say
-
Rapport Therapeutics partners with Tenacia for RAP-219 in greater china
-
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
-
Solid Biosciences raises $240 million in private placement
-
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
-
Form 3 Bain Capital Specialty For: Feb 18 Filed by: Hooper Caroline Willis
-
Form 3 Bain Capital Private For: Feb 18 Filed by: Hooper Caroline Willis
-
Burlington Stores, Inc. Reports Fourth Quarter and Full Year 2025 Earnings
-
Surf Internet Closes $407 Million Inaugural Fiber ABS with Strong Investor Demand
-
BluWave Recognizes Private Equity Firms Advancing Modern Growth Practices With 2026 Top PE Innovator Awards
-
Form 4 Bain Capital Specialty For: Mar 03 Filed by: Rusnak-Carlson Sabrina
-
Form N-23C3A Lincoln Bain Capital For: Mar 03
-
Form D/A Bain Capital Double Impa
-
Interra Health, created through the merger of DoseSpot and Arrive Health, ushers in a new era of transparency for patients and providers
-
Form 8-K Bain Capital Private For: Feb 27
-
Form 4 Lincoln Bain Capital For: Oct 14 Filed by: Lincoln Financial Investments Corp
-
Form 3/A Lincoln Bain Capital For: Sep 09 Filed by: LINCOLN NATIONAL CORP
-
Flux, the AI hardware engineer, announces $37M in new investment
-
Form 8-K Bain Capital Specialty For: Feb 26
-
Form 10-K Bain Capital Specialty For: Dec 31
-
Bain Capital Specialty Finance, Inc. Announces December 31, 2025 Financial Results and Declares First Quarter 2026 Dividend of $0.42 per Share
-
Form X-17A-5 BAIN CAPITAL MARKETS, For: Dec 31
-
Virgin Australia delivers strong profit growth despite rising cost pressures
-
Form NPORT-P Lincoln Bain Capital For: Dec 31
-
Veza Introduces Native Access Agents to Secure the Modern AI-Driven Enterprise with Enterprise Agent Identity Control Plane
-
Prophet Security Accelerates the Agentic AI SOC Movement with Strategic Investments from Amex Ventures and Citi Ventures
-
Advantage Solutions adds two directors to board
-
Advantage Solutions Appoints Thomas Turner and Frank Yao to Board of Directors
-
Genstar Names John Kufner to Strategic Advisory Board
-
Alkeus Pharmaceuticals Announces Presentation of Investigational Oral Gildeuretinol Data During the 49th Annual Meeting of the Macula Society Being Held February 25-28
-
Exclusive-Bain Capital explores sale or IPO of Dessert Holdings, sources say
-
Norm Ai and Microsoft: Legal & Compliance AI Built for the Way Work Actually Happens
-
69% of IT Leaders Report Data Security Keeps Them Up at Night, According to New Survey
-
Cogent Security Raises $42M Series A to Arm Security Teams With Autonomous AI Agents
-
Bain Capital Selects Alter Domus to Support Credit Portfolios
-
Form SCHEDULE 13G/A Canada Goose Holdings Filed by: Bain Capital Integral Investors 2008, L.P.
-
Form SCHEDULE 13G/A Kyverna Therapeutics, Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SCHEDULE 13G/A Rent the Runway, Inc. Filed by: Bain Capital Venture Fund 2009, L.P.
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-HR Bain Capital Life Scienc For: Dec 31
-
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form SCHEDULE 13G/A Pharvaris N.V. Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form SCHEDULE 13G/A BRP Inc. Filed by: Bain Capital Integral Investors II, L.P.
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
